Odonate Financial Statements From 2010 to 2024

ODTCDelisted Stock  USD 1.80  0.00  0.00%   
Odonate Therapeutics financial statements provide useful quarterly and yearly information to potential Odonate Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Odonate Therapeutics financial statements helps investors assess Odonate Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Odonate Therapeutics' valuation are summarized below:
Odonate Therapeutics does not presently have any trending fundamental ratios for analysis.
Check Odonate Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Odonate Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Odonate financial statements analysis is a perfect complement when working with Odonate Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Odonate Therapeutics Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Odonate Therapeutics Company Return On Equity Analysis

Odonate Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Odonate Therapeutics Return On Equity

    
  -0.86  
Most of Odonate Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Odonate Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Odonate Therapeutics has a Return On Equity of -0.8614. This is 159.41% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The return on equity for all United States stocks is 177.87% higher than that of the company.

Odonate Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Odonate Therapeutics's current stock value. Our valuation model uses many indicators to compare Odonate Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Odonate Therapeutics competition to find correlations between indicators driving Odonate Therapeutics's intrinsic value. More Info.
Odonate Therapeutics is considered to be number one stock in return on equity category among its peers. It is regarded second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Odonate Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Odonate Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Odonate Therapeutics Financial Statements

Odonate Therapeutics stakeholders use historical fundamental indicators, such as Odonate Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Odonate Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Odonate Therapeutics' assets and liabilities are reflected in the revenues and expenses on Odonate Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Odonate Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. The company was founded in 2013 and is based in New York, New York. Odonate Therapeutics operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 137 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Odonate Pink Sheet

If you are still planning to invest in Odonate Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Odonate Therapeutics' history and understand the potential risks before investing.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories